PHOTOPORATION OF NK92 CELLS WITH BIODEGRADABLE POLYDOPAMINE NANOSENSITIZERS AS A PROMISING STRATEGY FOR THE GENERATION OF CAR-NK CELL THERAPIES.

被引：0
作者：
Hinnekens, C. [1 ]
Harizaj, A. [1 ]
Goemaere, I. [1 ]
Berdecka, D. [1 ]
De Smedt, S. [1 ]
Vandekerckhove, B. [2 ]
Fraire, J. [1 ]
Braeckmans, K. [1 ]
机构：
[1] UGent, Lab Gen Biochem Phys Pharm, Ghent, Belgium
[2] Univ Ghent, Dept Diagnost Sci, Ghent, Belgium
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P060
引用
收藏
页码：A34 / A35
页数：2
相关论文
共 50 条
  • [21] Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
    Gurney, Mark
    O'Dwyer, Michael
    CANCERS, 2021, 13 (07)
  • [22] Generation of CAR-NK Cells Using a Notch-Mediated Cell Expansion and Differentiation Platform
    Chandrasekaran, Devikha
    Le, Quy
    Prieve, Mary
    Stoltzman, Carrie A.
    Cook, Jody
    Blake, Joseph M.
    Massey, Erin B.
    Meshinchi, Soheil
    Delaney, Colleen
    BLOOD, 2020, 136
  • [23] A novel CAR-NK cell therapy to target lung adenocarcinoma cells
    Zolov, Sergey
    Chuikov, Sergei
    Katkam, Shiva Krishna
    Shield, Delaney
    Keshamouni, Venkateshwar G.
    CANCER RESEARCH, 2024, 84 (06)
  • [24] EGFR/EGFRvIII-targeted CAR-NK cells as a promising allogeneic cell therapy for the treatment of solid tumors
    Reindl, L. M.
    Thul, S.
    Roller, B.
    Boenig, H.
    Klusmann, J. H.
    Roedel, F.
    Steinbach, J. P.
    Burger, M. C.
    Wels, W. S.
    Ullrich, E.
    KLINISCHE PADIATRIE, 2024, 236 (03): : 212 - 212
  • [25] Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma
    Liu, Shiyuan
    Guan, Tian
    Yang, Futian
    Zhang, Honglei
    Yao, Yao
    Huang, Jiman
    Zhao, Pengfei
    Huang, Wei
    Wu, Tailiang
    Lin, Hui
    Fu, Ting
    Chen, Shaoyu
    Dai, Pengzhan
    Ding, Zhechun
    Chen, Dongmei
    Li, Wei
    Zeng, Haoyu
    Zhang, Xianjun
    BMC CANCER, 2025, 25 (01)
  • [26] IL-27 IN A FOURTH GENERATION CAR ENHANCES CAR-NK CELL EFFECTOR FUNCTION
    Biggi, A. F.
    Silvestre, R. N.
    Tirapelle, M. C.
    de Azevedo, J. T.
    Covas, D.
    Malmegrim, K. C.
    Figueiredo, M. L.
    Picanco-Castro, V.
    CYTOTHERAPY, 2024, 26 (06) : S8 - S8
  • [27] Comparative Evaluation of Synthetic Cytokines for Enhancing Production and Performance of NK92 Cell-Based Therapies
    Deol, Simrita
    Donahue, Patrick S.
    Mitrut, Roxana E.
    Hammitt-Kess, Iva J.
    Ahn, Jihae
    Zhang, Bin
    Leonard, Joshua N.
    GEN BIOTECHNOLOGY, 2023, 2 (03): : 228 - 246
  • [28] Evolution of a Hyperactive TcBuster Transposase Enables Highly Efficient Non-Viral Generation of CAR-NK and CAR-T Cells for Combination Cell Therapies
    Skeate, Joseph G.
    Pomeroy, Emily
    Jones, Bryan
    Slipek, Nicholas
    Wick, Bryce
    Lahr, Walker
    Stelljes, Erin
    Patrinostro, Xiaobai
    Barnes, Blake
    Zarecki, Trevor
    Krueger, Joshua
    Bridge, Jacob
    Robbins, Gabrielle
    McCormick, Madeline
    Largaespada, David A.
    Otto, Neil
    Webber, Beau R.
    Moriarity, Branden S.
    MOLECULAR THERAPY, 2023, 31 (04) : 177 - 178
  • [29] CAR NK92 Cells Targeting BCMA Can Effectively Kill Multiple Myeloma Cells Both In Vitro and In Vivo
    Park, Eunhee
    Mun, Hui-jin
    Seo, Eunju
    Hwang, Seojin
    Lee, Jae Hee
    Song, Sukgil
    Sung, Hyeran
    Kim, Hoi-Yul
    Kwon, Mi-Jin
    BIOMEDICINES, 2024, 12 (01)
  • [30] Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
    Zhong, Yan
    Liu, Jingfeng
    CELL DEATH DISCOVERY, 2024, 10 (01)
12345